Anagrelide Hydrochloride Capsule shortage
Anagrelide Hydrochloride Capsule is currently listed in shortage by the FDA. The FDA lists 2 affected products. This page was last refreshed from FDA data on Sep 22, 2026.
Teva is permanently stopping its anagrelide hydrochloride capsules as a business decision. Other manufacturers — including the makers of Agrylin (anagrelide) — have not reported a shortage and still list both the 0.5 mg and 1 mg strengths as available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Anagrelide Hydrochloride Capsule. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Nov 19, 2025Currently in shortage2 of 2 products affected.
-
Nov 19, 2025First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Teva Pharmaceuticals USA, Inc. 📞 800-545-8800 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
These rows are manufacturer reports to the FDA for Anagrelide Hydrochloride Capsule — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Anagrelide Hydrochloride Capsule? options further down this page.
Why is Anagrelide Hydrochloride Capsule in shortage?
Teva Pharmaceuticals has made a business decision to permanently stop making their version of anagrelide hydrochloride capsules. This affects both their 0.5 mg capsules (60-count bottles) and their 1 mg capsules (60-count bottles). Teva hasn't shared a specific public reason beyond calling it a business decision, so unfortunately there isn't more detail available about why they made this choice.
It's worth knowing that this report only covers Teva's products specifically. Other manufacturers of anagrelide are separate from this report and are listed elsewhere on this page.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Anagrelide Hydrochloride Capsule, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Anagrelide Hydrochloride Capsule?
Anagrelide hydrochloride capsules are currently on the FDA drug-shortage list. I want to walk you through what this means for the strength you take and the steps that make sense next.
Both available strengths — the 0.5 mg and the 1 mg capsules — are affected, and neither is reported to have an available source right now. The manufacturer that filed this report, Teva Pharmaceuticals USA, has listed both strengths as to be discontinued. The reason given is a business decision to stop making the drug, not a safety problem. Because this is a discontinuation, this particular supply gap may be permanent, so a conversation with your prescriber is the right next step.
Please keep in mind that this report reflects only one manufacturer. Other companies still make the same medicine, so your pharmacy may be able to find it elsewhere.
- Do not stop, skip, or change your dose on your own.
- Ask your pharmacy to check wholesalers and other makers — the same medicine (anagrelide capsules, 0.5 mg and 1 mg) is listed from other manufacturers, though it may not be in local stock.
- If your capsules cannot be found, ask your prescriber or pharmacist about your options.
Manufacturer contact numbers are listed on this page for reference; your pharmacy usually handles those calls. This is general, national information and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Anagrelide Hydrochloride Capsule?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Anagrelide Hydrochloride Capsule is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Anagrelide | ANAGRELIDE HYDROCHLORIDE ANHYDROUS .5 mg/1 | Capsule · Oral | Torrent Pharmaceuticals Limited | 13668-0453-01 |
| Anagrelide | ANAGRELIDE HYDROCHLORIDE ANHYDROUS 1 mg/1 | Capsule · Oral | Torrent Pharmaceuticals Limited | 13668-0462-01 |
| Agrylin | ANAGRELIDE HYDROCHLORIDE ANHYDROUS .5 mg/1 | Capsule · Oral | Takeda Pharmaceuticals America, Inc. | 54092-0063-01 |
| Anagrelide | ANAGRELIDE HYDROCHLORIDE ANHYDROUS .5 mg/1 | Capsule · Oral | Chartwell RX, LLC | 62135-0312-12 |
| Anagrelide | ANAGRELIDE HYDROCHLORIDE ANHYDROUS 1 mg/1 | Capsule · Oral | Chartwell RX, LLC | 62135-0313-60 |
| Anagrelide | ANAGRELIDE HYDROCHLORIDE .5 mg/1 | Capsule · Oral | ANI Pharmaceuticals, Inc. | 70954-0879-10 |
| Anagrelide | ANAGRELIDE HYDROCHLORIDE 1 mg/1 | Capsule · Oral | ANI Pharmaceuticals, Inc. | 70954-0881-10 |
Therapeutic equivalents & pricing 9 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Anagrelide Hydrochloride 0.5 mg | Teva | 100 capsules | $0.573 | AB | Discontinued |
| anagrelide .5 mg | Torrent | 100 capsules | $0.734 | AB | Availability likely |
| Anagrelide .5 mg | Chartwell | 120 capsules | $0.734 | — | Availability likely |
| Anagrelide .5 mg | ANI | 100 capsules | $0.734 | AB | Availability likely |
| anagrelide 1 mg | Torrent | 100 capsules | $1.441 | AB | Availability likely |
| Anagrelide 1 mg | Chartwell | 60 capsules | $1.441 | — | Availability likely |
| Anagrelide 1 mg | ANI | 100 capsules | $1.441 | AB | Availability likely |
| Anagrelide Hydrochloride 1 mg | Teva | 100 capsules | — | AB | Discontinued |
| Agrylin .5 mg | Takeda | 100 capsules | — | — | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Identity & classification
Where does this data come from?
Other hematology shortages
Anagrelide Hydrochloride Capsule shortage FAQs
Is Anagrelide Hydrochloride Capsule in shortage?
Which products are affected?
When will Anagrelide Hydrochloride Capsule be available again?
Can I still get Anagrelide Hydrochloride somewhere?
What should I do if I take Anagrelide Hydrochloride Capsule?
Still have a question about the Anagrelide Hydrochloride Capsule shortage?
Ask a pharmacist about this shortage →View Anagrelide Hydrochloride Capsule on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.